References
[1] Boman, B.M. and Wicha, M.S. (2008) Cancer Stem Cells: A Step toward the Cure. Journal of Clinical Oncology, 26, 2795-2799.
http://dx.doi.org/10.1200/JCO.2008.17.7436
[2] Ginestier, C., Hur, M.H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., et al. (2007) ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome. Cell Stem Cell, 1, 555-567.
http://dx.doi.org/10.1016/j.stem.2007.08.014
[3] Silva, I.A., Bai, S., McLean, K., Yang, K., Griffith, K., Thomas, D., et al. (2011) Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival. Cancer Research, 71, 3991-4001.
http://dx.doi.org/10.1158/0008-5472.CAN-10-3175
[4] Clarke, M.F., Dick, J.E., Dirks, P.B., Eaves, C.J., Jamieson, C.H., Jones, D.L., et al. (2006) Cancer Stem Cells—Perspectives on Current Status and Future Directions: AACR Workshop on Cancer Stem Cells. Cancer Research, 66, 9339-9344.
http://dx.doi.org/10.1158/0008-5472.CAN-06-3126
[5] Choi, Y., Ingram, P.N., Yang, K., Coffman, Y., Iyengar, M., Bai, S., et al. (2015) Identifying an Ovarian Cancer Hierarchy Regulated by BMP2. PNAS, In Press.
http://dx.doi.org/10.1073/pnas.1507899112
[6] Landen, C.N., Goodman, B., Katre, A.A., Steg, A.D., Nick, A.M., Stone, R.L., et al. (2010) Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer. Molecular Cancer Therapeutics, 9, 3186-3199.
http://dx.doi.org/10.1158/1535-7163.MCT-10-0563
[7] Steg, A.D., Bevis, K.S., Katre, A.A., Ziebarth, A., Dobbin, Z.C., Alvarez, R.D., et al. (2012) Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer. Clinical Cancer Research, 18, 869-881.
http://dx.doi.org/10.1158/1078-0432.CCR-11-2188
[8] Lindahl, R. (1992) Aldehyde Dehydrogenases and Their Role in Carcinogenesis. Critical Reviews in Biochemistry and Molecular Biology, 27, 283-335.
http://dx.doi.org/10.3109/10409239209082565
[9] Chen, D., Cui, Q.C., Yang, H. and Dou, Q.P. (2006) Disulfiram, a Clinically Used Anti-Alcoholism Drug and Copper-Binding Agent, Induces Apoptotic Cell Death in Breast Cancer Cultures and Xenografts via Inhibition of the Proteasome Activity. Cancer Research, 66, 10425-10433.
http://dx.doi.org/10.1158/0008-5472.CAN-06-2126
[10] Zhang, H., Chen, D., Ringler, J., Chen, W., Cui, Q.C., Ethier, S.P., et al. (2010) Disulfiram Treatment Facilitates Phosphoinositide 3-Kinase Inhibition in Human Breast Cancer Cells in Vitro and in Vivo. Cancer Research, 70, 3996-4004.
http://dx.doi.org/10.1158/0008-5472.CAN-09-3752
[11] Yip, N.C., Fombon, I.S., Liu, P., Brown, S., Kannappan, V., Armesilla, A.L., et al. (2011) Disulfiram Modulated ROS-MAPK and NF-κB Pathways and Targeted Breast Cancer Cells with Cancer Stem Cell-Like Properties. British Journal of Cancer, 104, 1564-1574.
http://dx.doi.org/10.1038/bjc.2011.126
[12] Wang, W., McLeod, H.L. and Cassidy, J. (2003) Disulfiram-Mediated Inhibition of NF-κB Activity Enhances Cytotoxicity of 5-Fluorouracil in Human Colorectal Cancer Cell Lines. International Journal of Cancer, 104, 504-511.
http://dx.doi.org/10.1002/ijc.10972
[13] Lin, J., Haffner, M.C., Zhang, Y., Lee, B.H., Brennen, W.N., Britton, J., et al. (2011) Disulfiram Is a DNA Demethylating Agent and Inhibits Prostate Cancer Cell Growth. Prostate, 71, 333-343.
http://dx.doi.org/10.1002/pros.21247
[14] Morrison, B.W., Doudican, N.A., Patel, K.R. and Orlow, S.J. (2010) Disulfiram Induces Copper-Dependent Stimulation of Reactive Oxygen Species and Activation of the Extrinsic Apoptotic Pathway in Melanoma. Melanoma Research, 20, 11-20.
http://dx.doi.org/10.1097/CMR.0b013e328334131d
[15] Raha, D., Wilson, T.R., Peng, J., Peterson, D., Yue, P., Evangelista, M., et al. (2014) The Cancer Stem Cell Marker Aldehyde Dehydrogenase Is Required to Maintain a Drug-Tolerant Tumor Cell Subpopulation. Cancer Research, 74, 3579-3590.
http://dx.doi.org/10.1158/0008-5472.CAN-13-3456
[16] Coffman, L., Mooney, C., Lim, J., Bai, S., Silva, I., Gong, Y., et al. (2013) Endothelin Receptor-A Is Required for the Recruitment of Antitumor T Cells and Modulates Chemotherapy Induction of Cancer Stem Cells. Cancer Biology & Therapy, 14, 184-192.
http://dx.doi.org/10.4161/cbt.22959
[17] Vaccari, A., Ferraro, L., Saba, P., Ruiu, S., Mocci, I., Antonelli, T., et al. (1998) Differential Mechanisms in the Effects of Disulfiram and Diethyldithiocarbamate Intoxication on Striatal Release and Vesicular Transport of Glutamate. Journal of Pharmacology and Experimental Therapeutics, 285, 961-967.
[18] Yourick, J.J. and Faiman, M.D. (1991) Disulfiram Metabolism as a Requirement for the Inhibition of Rat Liver Mitochondrial Low Km Aldehyde Dehydrogenase. Biochemical Pharmacology, 42, 1361-1366.
http://dx.doi.org/10.1016/0006-2952(91)90446-C
[19] Hart, B.W. and Faiman, M.D. (1992) In Vitro and in Vivo Inhibition of Rat Liver Aldehyde Dehydrogenase by S-Methyl N, N-Diethylthiolcarbamate Sulfoxide, a New Metabolite of Disulfiram. Biochemical Pharmacology, 43, 403-406.
http://dx.doi.org/10.1016/0006-2952(92)90555-W
[20] Madan, A. and Faiman, M.D. (1994) Diethyldithiocarbamate Methyl Ester Sulfoxide, an Inhibitor of Rat Liver Mitochondrial Low Km Aldehyde Dehydrogenase and Putative Metabolite of Disulfiram. Alcoholism: Clinical and Experimental Research, 18, 1013-1017.
http://dx.doi.org/10.1111/j.1530-0277.1994.tb00075.x
[21] Lipsky, J.J., Shen, M.L. and Naylor, S. (2001) In Vivo Inhibition of Aldehyde Dehydrogenase by Disulfiram. Chemico-Biological Interactions, 130-132, 93-102.
http://dx.doi.org/10.1016/S0009-2797(00)00225-8
[22] Vasiliou, V. and Nebert, D.W. (2005) Analysis and Update of the Human Aldehyde Dehydrogenase (ALDH) Gene Family. Human Genomics, 2, 138-143.
[23] Moreb, J.S., Ucar, D., Han, S., Amory, J.K., Goldstein, A.S., Ostmark, B., et al. (2012) The Enzymatic Activity of Human Aldehyde Dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) Is Detected by Aldefluor, Inhibited by Diethylaminobenzaldehyde and Has Significant Effects on Cell Proliferation and Drug Resistance. Chemico-Biological Interactions, 195, 52-60.
http://dx.doi.org/10.1016/j.cbi.2011.10.007
[24] Marchitti, S.A., Orlicky, D.J., Brocker, C. and Vasiliou, V. (2010) Aldehyde Dehydrogenase 3B1 (ALDH3B1): Immunohistochemical Tissue Distribution and Cellular-Specific Localization in Normal and Cancerous Human Tissues. Journal of Histochemistry and Cytochemistry, 58, 765-783.
http://dx.doi.org/10.1369/jhc.2010.955773
[25] Rosen, J.M. and Jordan, C.T. (2009) The Increasing Complexity of the Cancer Stem Cell Paradigm. Science, 324, 1670-1673.
http://dx.doi.org/10.1126/science.1171837
[26] Sládek, N.E. (2003) Human Aldehyde Dehydrogenases: Potential Pathological, Pharmacological, and Toxicological Impact. Journal of Biochemical and Molecular Toxicology, 17, 7-23.
http://dx.doi.org/10.1002/jbt.10057
[27] Moore, S.A., Baker, H.M., Blythe, T.J., Kitson, K.E., Kitson, T.M. and Baker, E.N. (1998) Sheep Liver Cytosolic Aldehyde Dehydrogenase: The Structure Reveals the Basis for the Retinal Specificity of Class 1 Aldehyde Dehydrogenases. Structure, 6, 1541-1551.
http://dx.doi.org/10.1016/S0969-2126(98)00152-X